Social Wall
Effects of Ciltacabtagene Autoleucel in Patients With Multiple Myeloma
New Data on Pegcetacoplan in Patients With C3G and IC-MPGN
First Results From a Study Evaluating CAR-T Cell Therapy for Large B Cell Lymphoma
Results From the CEPHEUS Clinical Trial in Multiple Myeloma
Results from the CARTITUDE-1 Study in Patients With Multiple Myeloma
Results from the VERIFY Clinical Trial in Polycythemia Vera
Chronic Myeloid Leukemia: Advice to Newly Diagnosed Patients
Chronic Myeloid Leukemia: Treatment
Chronic Myeloid Leukemia: Overview and Landscape
Chronic Myeloid Leukemia: Overview, Treatment Options, and Advice
Linvoseltamab Combination Therapy in Patients With Relapsed/Refractory Multiple Myeloma
Phase 3 GLISTEN Trial in Patients With Primary Biliary Cholangitis
Linerixibat Reduces Itching in Patients with PBC
The I CAN Study is now enrolling adults diagnosed with
immunoglobulin A nephropathy (IgAN) to evaluate an investigational study treatment option that may improve kidney function and slow the progression of the disease in adults. Click here to learn more. ...https://icanclinicalstudy.alexionclinicaltrials.com/?utm_source=CheckRare&utm_medium=Social&utm_content=Awareness&utm_campaign=ICAN
Advice for Patients With Sickle Cell Anemia
A Patient’s Diagnostic Journey With Idiopathic Pulmonary Hemosiderosis (IPH)
Newly Approved Treatment Targets Underlying Cause of IgG4-Related Disease
Immunoglobulin A nephropathy (IgAN), also known as Berger’s disease, is a rare autoimmune disease that can cause kidney disease. Patients living with IgAN may be eligible for a clinical research study that may help improve kidney function and slow the progression of this disease…
The Impact of Hemophilia on Women and Girls
Efficacy of Atrasentan To Treat Patients With IgA Nephropathy
Marfan Syndrome: Diagnosis and Management
CheckRare July 10, 2025 9:42 am